14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CGEN ranks #19487 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Compugen Ltd. Stock Forecast NASDAQ:CGEN

$3.66 (-3.94%)

Volume: 1M

Closed: Jan 21, 2022

Hollow Logo Score: -6.829

Compugen Ltd. Stock Forecast

$3.66 (-3.94%)

Volume: 1M

Closed: Jan 21, 2022

Score Hollow Logo -6.829

Compugen Ltd. Company Profile

Azrieli Center

Holon 5885849

972 3 765 8585

www.cgen.com

Industry: Biotechnology

Sector: Healthcare

Compugen Ltd.

Description

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company primarily focuses on immune checkpoint target candidates to serve as drug targets for cancer immunotherapies addressing various cancer types and patient populations. Its antibody drug conjugate target candidates include CGEN-15001T, CGEN-15022, CGEN-15029, CGEN-15049, CGEN-15027, CGEN-15052, and CGEN-15092 for immuno-oncology; and therapeutic proteins comprise CGEN-15001 for autoimmune diseases. The company was incorporated in 1993 and is headquartered in Holon, Israel.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE